Medtech Ethiopia pioneers domestic industry growth through EPHARM acquisition

By Admin
Medtech Ethiopia has signaled its intentions in recent years through various acquisitions and diversifications, and is well on its way to benefiting fro...

Medtech Ethiopia has signaled its intentions in recent years through various acquisitions and diversifications, and is well on its way to benefiting from its most significant investment to date.

The Ethiopian pharmaceutical company’s recent acquisition of EPHARM (Ethiopian Pharmaceuticals Manufacturing Factory) signals a full circle in the business’s 16-year development, which initially saw it operate as a distributor for the latter to fill the demand gap in Ethiopia.

Click here to read the latest edition of Healthcare Global magazine!

Founder and Chief Executive Officer (CEO), Dr. Mohammed Nuri was the innovator who noticed the concerning trend and has not looked back since deciding to form the country’s first pharmaceutical supplier.  

“I am a doctor by background, and was really frustrated by the shortage of availability of pharmaceutical products in the country,” he said. “This is what pushed me to go into this field and with the Ethiopian market untested at the time, we grew exponentially.

RELATED TOPIC: Princess Alexandra Hospital: Nationally recognised for excellence, expertise

“From five staff members in a three room office, with capital of $50,000, we have now registered more than 300 pharmaceutical products from more than 20 global suppliers, and we are ISO certified and one of the top pharmaceutical companies in Ethiopia.”

EPHARM acquisition

EPHARM has been a government-owned organisation for the past 50 years, establishing an unrivalled reputation in the country and industry, making the acquisition a vital feather in the cap of Medtech Ethiopia.

RELATED TOPIC: CHUM: Montreal’s international health centre

With a total of 63,000 square meters of land to expand the EPHARM facilities, Dr. Nuri has taken the opportunity to ... Click here to read the rest of the article on Healthcare Global!

Let's connect!   

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19